Therapeutics

Assertio Therapeutics, Inc.: Professional Sales Representative - San Diego, CA

1 day ago   |   San Diego Biotechnology   |   5 articles

Assertio Therapeutics, Inc.: The Professional Sales Representative is responsible for implementing Assertio's marketing strategy by delivering proficient sales presentations to...
Read more ...

Lipoteichoic acid from the cell wall of a heat killed Lactobacillus paracasei D3-5 ameliorates aging-related leaky gut, inflammation and improves physical and cognitive functions: from C. elegans to mice

1 day ago   |   Springer

Abstract Increased inflammation associated with leaky gut is a major risk factor for morbidity and mortality in older adults; however, successful preventive and therapeutic...
Read more ...

Comparative transcriptomics reveals PrrAB-mediated control of metabolic, respiration, energy-generating, and dormancy pathways in Mycobacterium smegmatis

2 days ago   |   Springer

Abstract Background Mycobacterium smegmatis is a saprophytic bacterium frequently used as a genetic surrogate to study pathogenic Mycobacterium tuberculosis. The PrrAB...
Read more ...

3 Takeaways From the Resurrection of Biogen's Alzheimer's Drug

3 Takeaways From the Resurrection of Biogen's Alzheimer's Drug

2 days ago   |   Xconomy

The name of the experimental drug was heard so frequently in hotel hallways at the conference that it sounded like an incantation: aducanumab, aducanumab, aducanumab...
Read more ...

Ovarian cancer stem cells and targeted therapy

3 days ago   |   Springer

Abstract Background Ovarian cancer has the highest ratio of mortality among gynecologic malignancies. Chemotherapy is one of the most common treatment options for ovarian...
Read more ...

Fate Therapeutics: Scientist / Associate Scientist, Protein Chemistry/Molecular Engineering

3 days ago   |   San Diego Biotechnology

Fate Therapeutics: individual with expertise in protein chemistry and molecular biology to join a team dedicated to discovery and productization of novel cell therapies 92121...
Read more ...

Sage crushed by MOUNTAIN as phase 3 depression data fall short

3 days ago   |   Fierce Biotech   |   2 articles

Sage Therapeutics' key phase 3 trial in major depressive disorder has missed its primary endpoint. The failure of SAGE-217 to beat placebo wiped more than 50% off Sage's share...
Read more ...

Regulatory Affairs Associate - Sorrento Therapeutics - San Diego, CA

3 days ago   |   San Diego Biotechnology   |   3 articles

Utilize systems and tools for electronic document capture, generation, manipulation, scanning, and QC. Ensure final document components are electronically...From Sorrento...
Read more ...

Quality Control Scientist - Sorrento Therapeutics - San Diego, CA

3 days ago   |   San Diego Biotechnology   |   3 articles

Conduct QC tests following test protocols and procedures in compliance with quality system and cGMP regulations. WHAT WE ARE LOOKING FOR:From Sorrento Therapeutics - Thu, 05...
Read more ...

Sage Therapeutics Depression Drug Fails in Phase 3, Shares Fall 60%

Sage Therapeutics Depression Drug Fails in Phase 3, Shares Fall 60%

3 days ago   |   Xconomy   |   2 articles

An experimental Sage Therapeutics drug intended to alleviate depression symptoms quickly has failed to beat a placebo in a pivotal study, the company reported Thursday...
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

AstraZeneca Taps Gatehouse Bio to Identify Potential Drug Targets

AstraZeneca Taps Gatehouse Bio to Identify Potential Drug Targets

After joining AstraZeneca's Boston Bio Hub incubator last year, Gatehouse Bio is now teaming up with the pharma company to identify potential drug targets in respiratory and... Read more ...

IAmScience Mannie Liscum

IAmScience Mannie Liscum

For Mannie Liscum, thinking is a privilege, and his job gives him the chance to be fascinated by human's capacity to conceptualize and learn new things. “It's my goal to use as... Read more ...

Alert: Johnson Fistel Investigates Proposed Sale of ArQule, Inc.; Is $20 a...

SAN DIEGO, Dec. 9, 2019 /PRNewswire/ - Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of ArQule, Inc. breached... Read more ...

New Sanofi CEO Hudson adds next-gen cancer drug tech to the R&D quest...

When Paul Hudson lays out his R&D vision for Sanofi tomorrow, he will have a new slate of interleukin therapies and a synthetic biology platform to boast about. The French... Read more ...

AveXis Inc.: Senior Scientific Training Specialist - cGMP Gene Therapy

AveXis Inc.: OverviewReady to join a team committed to developing and commercializing gene therapies for patients and families devastated by rare neurological gene San Diego... Read more ...

Process Engineer I - Genentech - Oceanside, CA

Focus will be on one or more areas such as design, implementation and/or start-up of new and/or existing facilities with respect to process and/or clean utility...From... Read more ...

Pineoblastoma segregates into molecular sub-groups with distinct...

Abstract Pineoblastomas are rare, aggressive pediatric brain tumors of the pineal gland with modest overall survival despite intensive therapy. We sought to define the clinical... Read more ...

The majority of A-to-I RNA editing is not required for mammalian homeostasis

Abstract Background Adenosine-to-inosine RNA editing, mediated by ADAR1 and ADAR2, occurs at tens of thousands to millions of sites across mammalian transcriptomes. A-to-I... Read more ...

CRISPR System: A High-throughput Toolbox for Research and Treatment of...

Abstract In recent years, the innovation of gene-editing tools such as the CRISPR/Cas9 system improves the translational gap of treatments mediated by gene therapy. The... Read more ...

Exploration of cryptic organic photosensitive compound as Zincphyrin IV in...

Abstract Zincphyrin IV is a potential organic photosensitizer which is of significant interest for applications in biomedicine, materials science, agriculture , and chemistry... Read more ...